| Application no. and date | 22813008.4 (espacenet) (Federated) (European Patent Register), 20221014 | | Patent/reg. no. and date | DK/EP 4415693, 20260218 | | Publication date | 20240821 | | Priority no. and date | US 202163256432 P, 20211015 | | EP pub. no. and date |
EP 4415693 20240821 | | Effective date | | | Applicant/owner | Bioverativ Therapeutics Inc., 225 Second Avenue
Waltham MA 02451, US | | Applicant ref. no. | | | Inventor | CARLAGE, Tyler,
Waltham, Massachusetts 02451, US,
MAULDIN, Randall,
Waltham, Massachusetts 02451, US,
MCCOY, Timothy R.,
Waltham, Massachusetts 02451, US,
TAZI, Loubna Mzaalak,
Waltham, Massachusetts 02451, US | | Representative | | | Opponent | | | IPC Class | A61K 47/02 (2006.01) , A61K 47/10 (2017.01) , A61K 47/18 (2017.01) , A61K 47/26 (2006.01) , A61K 9/19 (2006.01) , A61P 7/04 (2006.01) | | Title | FORMULATIONS OF FACTOR VIII CHIMERIC PROTEINS AND USES THEREOF | | Int. application no. | US2022078097 | | Int. publication no. | WO2023064886 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
